NIMU is a high risk bet, though the rewards could be commensurate if it is able to realize its potential. So far the financials are nothing great, and the company does not have any regular stream of meaningful revenue. There is a declining trend over the past few years. The accumulated deficit is around $24 million. A recent article on SA, however, recommended to buy the stock mainly based on the prospect that OPKO Health (OPK) may be interested in the company. The author mentioned that NIMU and OPKO Health (OPK) have the same address as far as the headquarters is concerned. Dr. Frost, who is known to be astute as far as picking up companies with potential is concerned, may have invested in NIMU because its product compliments OPKO's long term strategy. Frost acquired NIMU shares at $0.05 in April. That changed the sentiment for the stock. As per the author, taking a stake in NIMU could be part of a larger strategy of Dr. Frost. NIMU's product, which can help diagnose health problems just through external sensors without invasive diagnostic procedures, is believed to have a lot of potential. It is important to remember, that the potential of the product may take time to be realized. Hence, the financials may not be positively impacted in the short term. Meanwhile, the stock has appreciated a lot, and has multiplied several times since January 2013. Despite the recent correction of 33%, it is still up 285% in 2013. Further, the recent selling by some insiders cannot be totally ignored. Frost's investments have done well recently, and pharmaceuticals / biotechnology sector has been is specialty. His investment in Biozone Pharmaceuticals (BZNE) has made a lot of news recently. Biozone owns a high potential drug delivery technology Qusomes. So, after such a huge run up, NIMU requires some significantly positive news flow to resume the uptrend.
Thanx for the summary investora. Sounds like the whole story. I own 5 other Dr. Frost stocks. 3 have made very good $$ and 2 are in incubation. Hope to add NIMU to the incubation list tomorrow at 0.272. Though the chart looks like it's consolidating now for a move soon. GLTU sir.